Satsuma Pharmaceuticals (STSA) Acquired by SNBL

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/6/2026

1. PTC
2. NVDA
3. PCVX
4. SPY
5. META
6. MSFT
7. GOOGL
8. GMAB
9. BBIO
10. BETR

Go back to Satsuma Pharmaceuticals (STSA) Acquired by SNBL

SNBL to Acquire Satsuma Pharmaceuticals

April 16, 2023 7:41 PM EDT

Transaction delivers immediate value and liquidity to Satsuma stockholders

SNBL to acquire all outstanding shares of Satsuma for upfront cash consideration of $0.91 per share

Satsuma stockholders to also receive non-tradeable CVR of up to $5.77 per share

With the goal of maximizing value for stockholders, Satsumas Board has carefully considered strategic options for Satsuma and STS101 and fully supports this transaction with SNBL

SOUTH SAN FRANCISCO, Calif., April 16, 2023 (GLOBE NEWSWIRE) --... More